CIK 0001668243
- Non-accelerated filer
- Smaller reporting company
UroGen Pharma Ltd.
Sign in to watch- Ticker
- URGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Israel
- Entity type
- Operating
- Phone
- +972 97707601
- Business address
- 9 HA'TA'ASIYA ST, RA'ANANA, Israel, 4365007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,037,646
- in 4 filings
Net −$3,037,646. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-06 | Nussbaum Ran Director | Option exercise · Stock Option (right to buy) | −1,030 | 0 | ||
| 2022-06-06 | Nussbaum Ran Director | Option exercise | +1,030 | $5.00 | $5K | 1,433,928 |
| 2022-06-06 | Nussbaum Ran Director | Option exercise · Stock Option (right to buy) | −1,030 | 0 | ||
| 2022-03-25 | Kim Dong Chief Financial Officer | Grant or award · Stock Option (right to buy) | +20,000 | 20,000 |
Page 13 of 13 · 244 trades